 Axogen Inc NASDAQ: AXGN announced topline results from its RECON Clinical Study comparing Avance Nerve Graft to conduits in digital nerve injuries. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral. 